23AndMe Sells Rights To Create Drugs Based On Users’ DNA
DNA testing company 23andMe has sold the rights to create a new drug based on their users’ DNA. The medication will be used to treat inflammatory diseases. According to New Scientist, 23andMe sold the rights to Spanish pharmaceutical company Almirall with hopes of using the data to create a drug for inflammatory diseases. 23andMe Vice … Read more